Skip to Content

TRC-00037 | Aflibercept (Eylea®) (Human) ELISA Kit | 96 Well

Product Overview

A Sandwich ELISA kit for the quantitative measurement of antibody against Aflibercept in human serum or plasma.

Aflibercept is a recombinant protein composed of the binding domains of two human vascular endothelial growth factor (VEGF) receptors fused with the Fc region of human immunoglobulin gamma 1 (IgG1). Aflibercept, as an ophthalmic agent, is used in the treatment of macular edema following Central Retinal Vein Occlusion (CRVO) and neovascular Age-Related Macular Degeneration (AMD). Compared to other anti-VEGF drugs like bevacizumab and ranibizumab, aflibercept has a higher binding affinity to VEGF-A. Aflibercept ELISA kit has been developed for specific quantification of Aflibercept concentration in human serum or plasma with high sensitivity and reproducibility. Aflibercept ELISA kit is based on the sandwich ELISA principle. Standards and samples (serum or plasma) are added in the microtiter plate coated with the reactant for aflibercept. After incubation, the wells are washed. The HRP conjugated probe is added and binds to aflibercept captured by the reactant on the surface of the wells. Following incubation wells are washed and the bound enzymatic activity is detected by addition of TMB chromogen substrate. Finally, the reaction is terminated with an acidic stop solution. The color developed is proportional to the amount of aflibercept in the sample or standard. Results of samples can be determined directly using the standard curve.

Assay Information

Assay FormatSandwich ELISA
Species ReactivityHuman
Sample TypePlasma,Serum
Detection MethodSandwich ELISA, Absorbance (450 nm)
Detection Wavelength450 nm
Kit Size96 Well

Performance Data

Detection Range30 - 1000 ng/ml
Sensitivity30 ng/ml,This ELISA kit is used for in vitro quantitative determination of Aflibercept,Cross Reactivity: Except for Aflibercept, there is no cross reaction with other therapeutic antibodies and native serum immunoglobins.,Recovery rate: &lt

Applications

This ELISA kit is used for quantitative measurement of Aflibercept in human serum and plasma

Features & Benefits

Assay Precision: Intra-Assay: CV < 30%; Inter-Assay: CV < 30% (CV (%) = SD/mean X 100),Sensitivity: 30 ng/ml,This ELISA kit is used for in vitro quantitative determination of Aflibercept,Cross Reactivity: Except for Aflibercept, there is no cross reaction with other therapeutic antibodies and native serum immunoglobins.,Recovery rate: <100±30% with normal human serum samples,Detection Range: 30 - 1000 ng/ml

Storage & Shipping

Storage+4°C
ShippingGel Pack
Shelf Life12 Months

Product Details

96Trace CATE4854-100
Supplier CATTRC-00037
Analyte / TargetAflibercept (Eylea®)
CategoryBiosimilar & Isotype Control ELISA Kits